(Godard, M. P. et al (2004) Body composition and hormonal adaptations associated with Forskolin consumption in overweight and obese Men. Obesity Res.; 13: 1335 – 1343)
In a randomized, double blind, placebo- controlled 12 weeks, 30 subjects study, reported that a dose of 250 mg of ForsLean® twice daily, significantly increased lean body mass and decreased body fat in obese male subjects (Figure 5). Additionally, forskolin administration resulted in a change in bone mass compared with the placebo group (p 0.05). There was a trend toward a significant increase for lean body mass in the forskolin group compared with the placebo group (p 0.097).
Also the serum free testosterone and total testosterone levels were significantly increased in the forskolin group compared to the placebo group (Figure 6).
Sabinsa Wins Again: Federal Court Denies Creative Compounds Motion
Listen to a brief video on ForsLean®
View past and recent advertisements
Innovative Ingredients Paper Weight loss approach
Sabinsa calls to readers' attention that some of the products, protocols and uses of the products described here in are or may be subject to various restrictions or limitations because of patents, exclusive or nonexclusive licenses, confidentiality agreements and other intellectual property or equivalent rights. Readers are advised to make an early and thorough investigation and inquiry into any product, protocol or use in which they may be interested, to see if any such rights might be applicable. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.